895 employees
Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.
$965M sweet spot round size
2013
$965M
from investors over 1 rounds
Alvotech raised $965M on July 7, 2024